FBXW7 and gastric cancer: miR-223, which also directly targets FBXW7, has been found to be significantly up-regulated in cisplatin-resistant gastric cancer cells SGC-7901 and BGC-823 as well as in H. pylori-infected gastric cancer tissue [125].